The Alzheimer's and Parkinson's Diseases (AD/PD) 2025 International Conference, conducted in April in Vienna, Austria, and online, stands as a pivotal event in neurodegenerative disease research. This hybrid gathering brings together global experts to delve into the latest advancements in Alzheimer’s and Parkinson’s diseases, emphasizing breakthroughs in treatment, translational research, early diagnosis, and clinical trials. By fostering interdisciplinary collaboration and highlighting the convergence of disease mechanisms, AD/PD 2025 aims to accelerate the development of innovative therapies and improve patient outcomes. The conference’s commitment to integrating ba...
